Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P01HL119165; P01CA221775
National Institutes of Health
Grant: 5P01CA221775-02
Precision Delivery and Imaging to Enhance Solid Tumor Therapy
National Institutes of Health
Grant: 1P01HL119165-01A1
Antibody Targeted Therapeutics
NCI NIH HHS
Grant: P01 CA221775
NHLBI NIH HHS
Grant: P01 HL119165
FWCI
0.97
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals